Up-to-date role of aflibercept in the treatment of colorectal cancer

Autor:	Jose Luis Cuadra-Urteaga, Nuria Mulet, Javier Ros, Elena Elez, Iosune Baraibar, Nadia Saoudi Gonzalez, Josep Tabernero, A. Valdivia, Francesc Salvà, D. Marmolejo
Rok vydání:	2021
Předmět:	0301 basic medicine Oncology medicine.medical_specialty Colorectal cancer Angiogenesis Recombinant Fusion Proteins VEGF receptors Clinical Biochemistry Leucovorin 03 medical and health sciences 0302 clinical medicine Internal medicine Antineoplastic Combined Chemotherapy Protocols Drug Discovery medicine Humans Aflibercept Pharmacology biology business.industry Public health Antiangiogenic therapy medicine.disease Receptors Vascular Endothelial Growth Factor 030104 developmental biology 030220 oncology & carcinogenesis biology.protein Camptothecin Fluorouracil Colorectal Neoplasms business medicine.drug
Zdroj:	Expert Opinion on Biological Therapy. 21:1315-1324
ISSN:	1744-7682 1471-2598
DOI:	10.1080/14712598.2021.1935231
Popis:	Introduction: Colorectal cancer (CRC) is a major public health problem. Despite major progress understanding the biological basis of this tumor added to the incorporation of optimized diagnostic an...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf57f170a11d61a10718b277040a89e8 https://doi.org/10.1080/14712598.2021.1935231 Zobrazit plný text záznamu